PACIFIC EDGE ORD FOR.EXEMPT NZX (PEB) Short Interest
PACIFIC EDGE ORD FOR.EXEMPT NZX (ASX:PEB) had 0.10% of shares reported as short positions as of 16 May 2026, representing 1,063,942 shares. PACIFIC EDGE ORD FOR.EXEMPT NZX operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 0.10%
- Reported positions
- 1,063,942
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
PEB
Pacific Edge
Pacific Edge is a global cancer diagnostics company focused on developing and commercializing bladder cancer diagnostic and prognostic tests. Their key product, Cxbladder, is a suite of non-invasive genomic urine tests used for risk stratification, rule-out, and surveillance of urothelial bladder cancer. The company operates directly in New Zealand, Australia, Singapore, and the United States, and...